APG-2449 | m-entrepreneurship.com

Product Name :
APG-2449

Search keywords :
APG-2449

drugId :
null

Target Vo:
Anaplastic lymphoma kinase

Target Vo Short Name :
ALK

Moa_Name:
Focal adhesion kinase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Jiangsu Yasheng Pharmaceutical Development Co Ltd

Active Company_Name :
Ascentage Pharma Group Inc

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HtrA2 Antibody (YA726)
TOP2A Antibody
STAT1 alpha Antibody: STAT1 alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to STAT1 alpha. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts